US Patent 7910598 Phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase
Patent 7910598 was granted and assigned to Natco Pharma on March, 2011 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7910598 Phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.